Safe and feasible outpatient treatment following induction and consolidation chemotherapy for patients with acute leukaemia
Authors:
- Tom MøllerTMTom Møller
- Ove Juul NielsenONOve Juul Nielsen
- Pernille WelinderPWPernille Welinder
- Anne DünweberADAnne Dünweber
- Maiken HjermingMHMaiken Hjerming
- Claus MoserCMClaus Moser
- Lars KjeldsenLKLars Kjeldsen
- 11 March 2010
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 84 (4) , 316-322
Abstract
Traditionally, patients with acute leukaemia are admitted to hospital during chemotherapy‐induced pancytopenia, although a few recent reports have reported the feasibility and safety of outpatient treatment. We have developed an outpatient treatment programme for patients with acute leukaemia incorporating comprehensive patient education for self‐care management at home during pancytopenia and involvement of patients in care of their tunnelled central venous catheter (CVC). During neutropenia, patients are treated with prophylactic ciprofloxacine, amoxicillin/clavulanic acid and fluconazole. Herein, we report the results of outpatient treatment of 60 patients with acute leukaemia (54 with acute myeloid leukaemia) followed prospectively in the period from March 2004 to 2007. After induction chemotherapy, outpatient treatment was possible after 48 of 73 induction courses, with no readmission in 19 of these (40%). A total of 129 consolidation courses were administered with outpatient treatment following 116 of these, with no readmission in 69 (59%). The median number of days spent at home with neutrophils below 0.5 × 109/L was 8 d per course following induction and 12 d following consolidation chemotherapy. The predominant cause of readmission was neutropenic fever, in most instances of unknown origin. Coagulase‐negative staphylococci and Enterococcus faecium were the most frequently identified bacteria in blood cultures, whereas only four positive blood cultures with multiresistant Escherichia coli were identified in the entire patient cohort, the latter exclusively observed in patients receiving antibiotic prophylaxis. The majority of the patients were able to take care of their CVC including change in dressing and heparin flushing. There were 12 CVC‐related infections. There were no treatment‐related deaths. We conclude that outpatient treatment of patients with acute leukaemia is feasible and safe.Keywords
This publication has 14 references indexed in Scilit:
- Informal Caregiver Burden among Survivors of Prolonged Mechanical VentilationAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Case-Control Comparison of At-Home to Total Hospital Care for Autologous Stem-Cell Transplantation for Hematologic MalignanciesJournal of Clinical Oncology, 2006
- Shifting to outpatient management of acute myeloid leukemia: a prospective experienceAnnals of Oncology, 2006
- Patient education—a strategy for prevention of infections caused by permanent central venous catheters in patients with haematological malignancies: a randomized clinical trialJournal of Hospital Infection, 2005
- Information giving and decision-making in patients with advanced cancer: A systematic reviewSocial Science & Medicine, 2005
- Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and NeutropeniaNew England Journal of Medicine, 2005
- Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopeniaAnnals of Oncology, 2005
- Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital careBlood, 2002
- Outpatient Supportive Care Following Chemotherapy for Acute Myeloblastic LeukemiaLeukemia & Lymphoma, 2001
- A Double-Blind Comparison of Empirical Oral and Intravenous Antibiotic Therapy for Low-Risk Febrile Patients with Neutropenia during Cancer ChemotherapyNew England Journal of Medicine, 1999